Table 2.

Regression models of the relationship between baseline cerebral blood flow composites and cardiometabolic risk at two-year follow-up

	Model 1	Model 2	Model 3
Baseline Frontostriatal CBF	0.26 **	0.26 **	0.26 **
	[0.08, 0.44]	[0.08, 0.44]	[0.07, 0.45]
Baseline Frontoparietal CBF	0.01	0.01	−0.03
	[−0.16, 0.18]	[−0.17, 0.18]	[−0.22, 0.15]
Baseline Insular-Subcortical CBF	−0.07	−0.07	−0.07
	[−0.25, 0.11]	[−0.25, 0.11]	[−0.25, 0.12]
Baseline Cardiometabolic Risk	0.68 ***	0.68 ***	0.68 ***
	[0.55, 0.81]	[0.54, 0.81]	[0.54, 0.82]
Baseline Total CBF		−0.03	0.01
		[−0.16, 0.11]	[−0.14, 0.15]
Age			−0.01
			[−0.16, 0.14]
Sex			−0.23
			[−0.55, 0.08]
Race			0.01
			[−0.30, 0.32]
Education			0.03
			[−0.13, 0.19]
N	109	109	109
R2	0.54	0.54	0.55

Standardized regression coefficients are reported with the 95% confidence interval below in brackets. Each model is adjusted for cardiometabolic risk at baseline. Model 1 is unadjusted for any further covariates. Model 2 is adjusted for total cerebral blood flow at baseline. Model 3 is also adjusted for age, sex, race, and education. CBF = Cerebral blood flow;

^***p < 0.001;

^**p < 0.01;

^*p < 0.05.